Setia Vishwas

USReporting entityCFO

Insider

Setia Vishwas

USReporting entityCFO

Transactions

Issuers

Buys / Sells

0/8

Last tx

06 May 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
MapLight Therapeutics, Inc.	356,256	reported	06 May 2026	tx 13+258,523−69,753

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
04 May 2026	SALE	MapLight Therapeutics, Inc.	4,803	27.36 USD	10b5-1
04 May 2026	SALE	MapLight Therapeutics, Inc.	8,989	28.28 USD	10b5-1
04 May 2026	SALE	MapLight Therapeutics, Inc.	325	29.56 USD	10b5-1
04 May 2026	SALE

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
MapLight Therapeutics, Inc.	356,256	reported	06 May 2026	tx 13+258,523−69,753

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
04 May 2026	SALE	MapLight Therapeutics, Inc.	4,803	27.36 USD	10b5-1
04 May 2026	SALE	MapLight Therapeutics, Inc.	8,989	28.28 USD	10b5-1
04 May 2026	SALE	MapLight Therapeutics, Inc.	325	29.56 USD	10b5-1
04 May 2026	SALE